Adirondack Research & Management’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.16M Buy
87,067
+6,300
+8% +$102K 1.42% 22
2021
Q2
$1.5M Sell
80,767
-42,381
-34% -$713K 1.75% 18
2021
Q1
$1.85M Sell
123,148
-31,940
-21% -$511K 2.19% 9
2020
Q4
$2.24M Sell
155,088
-58,312
-27% -$706K 3.06% 3
2020
Q3
$1.74M Sell
213,400
-25,500
-11% -$208K 2.42% 12
2020
Q2
$1.62M Buy
238,900
+8,000
+3% +$51.9K 2.12% 17
2020
Q1
$1.63M Sell
230,900
-141,920
-38% -$1.15M 2.27% 16
2019
Q4
$3.66M Sell
372,820
-61,100
-14% -$643K 3.17% 6
2019
Q3
$4.76M Sell
433,920
-10,000
-2% -$103K 4.16% 1
2019
Q2
$5.16M Sell
443,920
-27,500
-6% -$280K 3.7% 1
2019
Q1
$4.5M Sell
471,420
-15,500
-3% -$171K 2.8% 6
2018
Q4
$4.69M Sell
486,920
-34,257
-7% -$382K 2.93% 6
2018
Q3
$7.43M Hold
521,177
2.78% 2
2018
Q2
$6.25M Hold
521,177
2.44% 5
2018
Q1
$6.44M Sell
521,177
-52,856
-9% -$751K 2.58% 3
2017
Q4
$8.35M Hold
574,033
3.28% 1
2017
Q3
$8.17M Hold
574,033
3.19% 3
2017
Q2
$7.33M Hold
574,033
2.85% 4
2017
Q1
$7.28M Buy
574,033
+18,372
+3% +$218K 2.61% 4
2016
Q4
$5.67M Buy
555,661
+127,100
+30% +$1.45M 1.93% 17
2016
Q3
$5.64M Buy
428,561
+67,302
+19% +$900K 2.04% 14
2016
Q2
$4.59M Hold
361,259
1.72% 20
2016
Q1
$4.77M Buy
361,259
+12,200
+3% +$160K 1.73% 19
2015
Q4
$5.37M Hold
349,059
1.94% 17
2015
Q3
$4.33M Hold
349,059
1.66% 22
2015
Q2
$4.78M Buy
349,059
+63,600
+22% +$859K 1.75% 23
2015
Q1
$3.41M Buy
285,459
+64,710
+29% +$791K 1.32% 38
2014
Q4
$2.82M Buy
220,749
+20,000
+10% +$255K 1.06% 44
2014
Q3
$2.69M Hold
200,749
1% 51
2014
Q2
$3.22M Buy
200,749
+10,000
+5% +$156K 1.09% 48
2014
Q1
$3.44M Hold
190,749
1.32% 36
2013
Q4
$2.95M Hold
190,749
1.43% 29
2013
Q3
$2.84M Hold
190,749
1.63% 16
2013
Q2
$2.47M Buy
+190,749
New +$2.56M 1.84% 12

Other funds holding MDRX

Adirondack Research & Management's MDRX Position: Q3 2021 in Review

Adirondack Research & Management increased its Veradigm Inc. Common Stock (MDRX) stake by 7.8% in Q3 2021, buying an estimated $102K and bringing the position to 87,067 shares worth $1.16M. The position accounts for 1.42% of the portfolio, ranked #22.

Adirondack Research & Management first reported a position in MDRX in Q2 2013 and has held it in 34 quarters since. The position peaked at $8.35M in Q4 2017. 224 funds tracked by Wall St. Rank hold MDRX as of Q3 2021.

  • Adirondack Research & Management held 87,067 shares of Veradigm Inc. Common Stock worth $1.16M as of Q3 2021.
  • Adirondack Research & Management bought 6,300 Veradigm Inc. Common Stock shares in Q3 2021, an estimated $102K.
  • Veradigm Inc. Common Stock made up 1.42% of Adirondack Research & Management's portfolio in Q3 2021, its #22 holding.
  • Adirondack Research & Management first reported a position in Veradigm Inc. Common Stock in Q2 2013 and has held it in 34 quarters since.
  • Adirondack Research & Management's Veradigm Inc. Common Stock position peaked at $8.35M in Q4 2017.
  • 224 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2021.

Based on Adirondack Research & Management's 13F filing for Q3 2021, filed 29 Oct 2021.